Advertisement

The experimental biologist and the medical scientist in the pharmaceutical industry

Chapter
  • 45 Downloads
Part of the Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques book series (PDR, volume 24)

Abstract

When I was invited to speak to you today I hesitated before accepting. On the one hand this paper offered an ideal opportunity to present a balanced picture of research in the pharmaceutical industry. There is no denying the fact that experimental biologists and medical scientists in industry are familiar with life and work in the university department, because it is there that they received their training and embarked upon their careers. The same however, cannot be said for their colleagues in academic institutions who may be poorly informed, and perhaps sometimes even misinformed, about the true situation in the research-based pharmaceutical industry.

Keywords

Pharmaceutical Industry Medical Scientist Experimental Biologist Pharmaceutical Research Postgraduate Training 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B. Berde: Industrial research in the quest for new medicines. Clin. exp. Pharmac. Physiol. 1, 183–195 (1974).CrossRefGoogle Scholar
  2. 2.
    B. Berde: Industrial research in the quest for new medicines. Prog. Drug Res. 20, 143–157 (1976).Google Scholar
  3. 3.
    W.C. Gibson: The cost of not doing medical research. Editorial in: JAMA 242, 1529 (1979).CrossRefGoogle Scholar
  4. 4.
    A.H. Maslow: A theory of human motivation. In: Readings in managerial psychology, p. 6–24. Eds. H.J. Leavitt and L.R. Pondy. University of Chicago Press, Chicago, London 1964. [Abridged from the Psychological Review, L, p. 370–396 (1943).]Google Scholar
  5. 5.
    D. Stetten, Jr.: The cathedrals of science. Persp. Biol. Med. 22, 311–319 (1979).Google Scholar
  6. 6.
    J. Thesing: Industrielle Arzneimittelforschung - Voraussetzungen und Möglichkeiten. Pharma-Industrie 39, 305–311 (1977).Google Scholar
  7. 7.
    J.B. Wyngaarden: The clinical investigator as an endangered species. New Engl. J. Med. 301, 1254–1259 (1979).Google Scholar

Copyright information

© Birkhäuser Verlag Basel 1980

Authors and Affiliations

  1. 1.Pharmaceutical DivisionSandoz Ltd.BaselSwitzerland

Personalised recommendations